| pubmed-article:18381567 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18381567 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18381567 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:18381567 | lifeskim:mentions | umls-concept:C0010055 | lld:lifeskim |
| pubmed-article:18381567 | lifeskim:mentions | umls-concept:C0034266 | lld:lifeskim |
| pubmed-article:18381567 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:18381567 | lifeskim:mentions | umls-concept:C0206034 | lld:lifeskim |
| pubmed-article:18381567 | pubmed:issue | 15 | lld:pubmed |
| pubmed-article:18381567 | pubmed:dateCreated | 2008-4-16 | lld:pubmed |
| pubmed-article:18381567 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18381567 | pubmed:abstractText | Coronary artery bypass graft (CABG) surgery is frequently performed and effective; however, perioperative complications related to ischemia-reperfusion injury, including myocardial infarction (MI), remain common and result in significant morbidity and mortality. MC-1, a naturally occurring pyridoxine metabolite and purinergic receptor antagonist, prevents cellular calcium overload and may reduce ischemia-reperfusion injury. Phase 2 trial data suggest that MC-1 may reduce death or MI in high-risk patients undergoing CABG surgery. | lld:pubmed |
| pubmed-article:18381567 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18381567 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18381567 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18381567 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18381567 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18381567 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18381567 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18381567 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18381567 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:18381567 | pubmed:issn | 1538-3598 | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:HarringtonRob... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:CarrierMichel... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:MehtaRajendra... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:AlexanderJohn... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:Bennett-Guerr... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:HasselbladVic... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:SchulerGerhar... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:TardifJean-Cl... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:MackMichael... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:EllisStephen... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:MenaschePhili... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:KhalilAhmadA | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:CoteRobertR | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:MEND-CABG... | lld:pubmed |
| pubmed-article:18381567 | pubmed:author | pubmed-author:EmeryRobert... | lld:pubmed |
| pubmed-article:18381567 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18381567 | pubmed:day | 16 | lld:pubmed |
| pubmed-article:18381567 | pubmed:volume | 299 | lld:pubmed |
| pubmed-article:18381567 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18381567 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18381567 | pubmed:pagination | 1777-87 | lld:pubmed |
| pubmed-article:18381567 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:meshHeading | pubmed-meshheading:18381567... | lld:pubmed |
| pubmed-article:18381567 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18381567 | pubmed:articleTitle | Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. | lld:pubmed |
| pubmed-article:18381567 | pubmed:affiliation | Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina 27715 , USA. john.h.alexander@duke.edu | lld:pubmed |
| pubmed-article:18381567 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18381567 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18381567 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18381567 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18381567 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18381567 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18381567 | lld:pubmed |
